Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.2K
Overview
44.2K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

476
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
476

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematic review of the use of antiretroviral drugs to prevent HIV in neonates and infants.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Newborns with sickle cell trait have distinct peripheral blood molecular signatures across the first week of life.

Blood. Red cells & iron·2026
Same author

Charting the Path Forward for HIV Immune-Based Prevention: Contributions of the Division of AIDS at NIAID.

Vaccines·2026
Same author

Early immune events during SARS-CoV-2 infection impact memory T and B cell responses.

Communications biology·2026
Same author

Population-specific heterogeneity in ontogeny of the broadly-conserved blood transcriptional program during the first week of life.

Nature communications·2026
Same author

Sphingosine-1-Phosphate Receptor and Kinase Expression in the Reproductive Tract Is Associated with HIV Infection and Preterm Birth in a Cohort of Pregnant Women in Zambia.

Viruses·2026

Related Experiment Video

Updated: Jun 14, 2025

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

1.8K

Precision adjuvants for pediatric vaccines.

Anjali Singh1, César Boggiano1, Dwight E Yin1

  • 1Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852, USA.

Science Translational Medicine
|September 4, 2024
PubMed
Summary

Identifying the best vaccine adjuvants for children is crucial for improving immune responses. Understanding age-specific adjuvants will lead to safer, more effective pediatric vaccines against infectious diseases.

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.7K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

606

Related Experiment Videos

Last Updated: Jun 14, 2025

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

1.8K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.7K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

606

Area of Science:

  • Pediatric immunology
  • Vaccine development
  • Adjuvant research

Background:

  • Pediatric vaccine design requires optimizing immune responses for different age groups.
  • Current vaccine adjuvants may not effectively harness age-specific immune pathways.
  • Enhancing immunogenicity magnitude, breadth, and durability is a key challenge.

Purpose of the Study:

  • To identify optimal vaccine adjuvants tailored for pediatric populations.
  • To understand how adjuvants interact with age-specific immune pathways.
  • To inform the development of next-generation pediatric vaccines.

Main Methods:

  • Review of existing literature on pediatric immune responses to vaccination.
  • Analysis of adjuvant mechanisms in relation to age-dependent immunity.
  • Comparative studies of adjuvant efficacy in preclinical pediatric models (if applicable).

Main Results:

  • Key immunological pathways that differ across pediatric age groups have been identified.
  • Specific adjuvant properties that correlate with enhanced immunogenicity in children are highlighted.
  • Gaps in current knowledge regarding age-specific adjuvant effects are outlined.

Conclusions:

  • Optimal vaccine adjuvants must consider the unique immunological landscape of pediatric populations.
  • Further research into age-specific adjuvants is essential for advancing pediatric vaccine efficacy.
  • This understanding will facilitate the precision development of safe and effective vaccines for children.